has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline:
It is available at the link below:Making sense of the Alzheimer's drug pipelineFierceBiotechResearch
March 15, 2011 — 7:53am ET
By Howard LovyRead the full article
If this area is new to you, the article will give you the names of some candidates that you can learn about as part of your introduction. There are many other overview articles and public resources available to you concerning clinical-trials research. You might wish, for example, to cross reference the names cited here with the ClinicalTrials.gov database.
If you are a Brain Awareness Week visitor, you can visit the Alzheimer's Association or other national organizations in your country to learn more about Alzheimer's disease and dementia.
Labels: Alzheimer, clinical trial, dementia, neurodegenerative, neuroimaging, neuropsychology